Q3-2017 Updated - Valuation & Quarterly Thoughts: The

New Post Public Reply Private Reply Replies (0) Message Board
ebrie014
671
Q3-2017 Updated - Valuation & Quarterly Thoughts:

The Company & Management continues to demonstrate promising results.

Overall;

- Top-line results were very impressive with 42%+ growth over last year (even with lower volumes due to hurricanes!)
- Gross margins increased from Q2-17 from 45.7% to 46.4% in Q3-17 (albeit lower than last year)
- SG&A did increase but is fairly in line on a proportionate basis to last Q at 27.5% of revenue vs. 27.2% in Q2 (reasonable given they are ramping up so many programs - many of which will hopefully be one-time cost as part of set-up)
- By my own EBITDA calculations (which is how I like to look at things) EBITDA was 752k this Quarter vs. 630k in the same quarter last year
-To obtain between 15-15.5M over the whole year the Company would need to have a Q4 of 4.4M to 4.9M which means the growth has to be between 44% to 60% over Q4-16. Not to mention the Company must have fairly good certainty on these numbers as we only have a month and a half left to the 2017FY
- Impressive program growth- currently at 202 programs and 1.5M+ cardholders up from 120 and 1M as of the 2016 year end. 2018 should be a spectacular year as the cardholder base has grown substantially which means a much larger client base generating higher overall revenues.
- Given the currently available information, my "reasonable targets" for the stock based on industry multiples are 1.42$ based on the 2017FYE and 2.08$ for 2018FYE.

_____________________________________________________________________
Valuation (including next FY estimates)

Current Fiscal Year Revenue: (46.5% growth) ~15.25M in 2017 (mid-point of guidance) / 2018FY estimate:21.3M (assume 40% growth)
Gross margins: 47% ~7.1M for 2017 / 10M for 2018
SG&A as a % of revenue 26.50% ~ 4.041M for 2017 / 5.55M for 2018
D&A and other: ~984k for 2017 / 1.2M for 2018
EBITDA:3.1M for 2017 / 4.4M for 2018
NI:2.1M for 2017 / 3.2M for 2018
F.d. share Count: 44.5M
Cash balance: 1.9M
LT debt:0$
**all multiples come from S&P capitalIQ from companies in a similar industry.


All methods use Median multiples to be more conservative (I have removed Visa and MC from the comps to not skew it to the upside).

Method 1 - EV/Sales:

EV/Sales Multiple:4.4x

15.25M*4.4=EV of 67.1M add back cash less debt=equity value of 69M/44.5M shares gives a share value of 1.55$/share


Method 2 - EV/EBITDA:

EV/EBITDA Multiple:16.5x

3.1M*16.5x=EV of 51.5M add back cash less debt=53.45M/44.5M= 1.20$/share

Method 3 - P/E:

P/E Multiple: 32.3x

NI of 2.1M/44.5M shares= 0.0472*32.3x=1.52$/share

Based on the above calculations an average target of ~1.42$/share is within reach if the company trades towards its fair value and hits its guidance. Using the same metrics, and continued top-line growth of 35-40% growth, a 2.08$ target would not be out of reach in the following fiscal year. (and if they got bought out - I could easily see someone taking them out between 3-5$/share)


Best of luck!

E.

Paysign, Inc. (PAYS) Stock Research Links

PAYS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading

Top 5 Most Recently Viewed Articles

ketteQ Raises $20M to Propel AI-Driven Supply Chain Solutions

Updated Category News Views 173

ketteQ Secures Significant Funding for Global Advancement Funding round supports ketteQ's mission to deliver adaptive planning, AI-powered insights, and measurable results in months, not years. ketteQ, a leader in adaptive supply chain planning solutions, has successfully raised $20 million in Series B funding, spearheaded by Vocap Partners. This fresh funding is set to...

Continue Reading
Cathie Wood's ARK Funds Make Strategic Moves in Tech Investments

Updated Category News Views 340

Overview of ARK's Recent Trading Activity Cathie Wood's ARK ETFs are well-known for their assertive trading strategies, and the most recent report reveals their latest stock moves. The firm has made headlines again by announcing a series of buy and sell transactions that display its ongoing commitment to innovation and growth in the tech sector. Let's dive into the...

Continue Reading
NEWTON GOLF Unveils $1 Million Share Repurchase Initiative

Updated Category News Views 119

NEWTON GOLF Announces Share Repurchase Authorization CAMARILLO, CA -- NEWTON GOLF Company (Nasdaq: SPGC), a leading innovator in the golf industry, has announced an authorization for a share repurchase program amounting to $1 million. This decision reflects a robust strategy to leverage market conditions and enhance shareholder value. The repurchase program will commence...

Continue Reading
Veritone Class Action: Stakes High for Shareholders

Updated Category News Views 3

Veritone's Legal Turbulence: Class Action Looms Alright, folks, here we go—a class action's got Veritone, Inc. (NASDAQ: VERI) in hot water, and it's not looking pretty. Legal eagles over at Robbins LLP are spearheading this suit, claiming the AI company botched its financial reporting. If you're holding VERI shares from October 14, 2025, through April 14, 2026, listen...

Continue Reading
TimelyCare Excellently Recognized for Mental Health Support

Updated Category News Views 180

TimelyCare Receives Prestigious Award for Mental Health Advocacy TimelyCare, known as higher education's most trusted virtual health and well-being provider, is honored to be recognized in the "Best in Business" list by Inc. for its exceptional advocacy in mental health. A Commitment to Student Health and Wellness As a winner in the Mental Health Advocacy category,...

Continue Reading